A PET scan of the brain is a type of imaging test that measures how actively your brain cells are working. Unlike an MRI or CT scan, which take detailed pictures of your brain’s structure, a PET scan reveals function: which areas are burning through energy, which are sluggish, and whether abnormal patterns point to disease. It’s most often ordered when structural imaging hasn’t provided a clear answer.
How a Brain PET Scan Works
Your brain runs on glucose. A PET scan exploits this by introducing a small amount of radioactive glucose (called FDG) into your bloodstream through an IV. As the tracer circulates, brain cells that are more active pull in more of this tagged sugar, while less active areas absorb less. The scanner then detects the tiny energy signals emitted by the radioactive atoms, building a color-coded map of metabolic activity across your brain.
Areas with high glucose uptake appear brighter on the scan. Areas with reduced activity appear dimmer. This contrast is what makes PET uniquely useful: it can reveal functional problems that exist long before a tumor or structural change becomes visible on other types of imaging.
What Conditions It Helps Diagnose
Brain PET scans are typically reserved for situations where an MRI or CT scan didn’t provide enough clarity. The most common reasons your doctor might order one include:
- Alzheimer’s disease and other dementias, particularly when standard tests are inconclusive. Newer tracers can detect the buildup of abnormal proteins in the brain that are hallmarks of Alzheimer’s, sometimes years before significant symptoms appear.
- Epilepsy, specifically to locate the origin of seizures before surgery. Between seizures, the area responsible often shows reduced metabolic activity, making it visible on PET.
- Brain tumors, both for initial diagnosis and to monitor whether treatment is working. Tumor cells tend to consume glucose at a much higher rate than surrounding healthy tissue.
- Parkinson’s disease, to distinguish it from other movement disorders that look similar on clinical exam and to help predict how the disease may progress.
- Unexplained coma, to evaluate which brain regions still have metabolic activity.
How Accurate Is It?
For Alzheimer’s detection, brain PET scans are remarkably reliable. In autopsy-confirmed studies, tracers designed to detect amyloid protein plaques reached 96% sensitivity, meaning they correctly identified the disease in nearly all patients who had it. The standard glucose-based PET scan had 80% sensitivity for the same task. When both types of PET results agreed, combined sensitivity hit 97% with 98% specificity.
In early-stage disease, the difference was even more striking. Amyloid-targeting PET scans caught 100% of early cases, while glucose-based scans detected only 69%. This is one reason amyloid PET has become increasingly important in evaluating people with mild cognitive symptoms.
Different Tracers for Different Questions
FDG, the radioactive glucose, is the workhorse tracer for general brain PET imaging. But depending on what your doctor is looking for, a different tracer may be used. Some tracers bind specifically to the amyloid plaques associated with Alzheimer’s. Others target tau protein tangles, another Alzheimer’s hallmark. For Parkinson’s disease, a tracer that tracks dopamine production in the brain can reveal characteristic deficits. Each tracer is designed to light up a specific biological process, turning the PET scan into a targeted investigation rather than a general survey.
What to Expect During the Procedure
You’ll need to fast for four to six hours before the scan so your blood sugar is at a stable, normal level. This matters because high blood sugar competes with the tracer for entry into brain cells, which can wash out the image. If your blood glucose is above 160 mg/dL at the time of the appointment, the scan will typically be rescheduled.
You can continue taking your regular medications, but your care team will want to know what you’re on, particularly sedatives, antiseizure drugs, psychiatric medications, or corticosteroids, since these can affect brain metabolism patterns. For Parkinson’s patients, whether the scan is done in a medication “off” state matters because levodopa can alter regional brain activity.
The appointment itself has two phases. First, the tracer is injected through an IV, and then you wait quietly for up to 60 minutes while your brain absorbs it. During this uptake period, you’ll be asked to rest in a dimly lit, quiet room. Talking, reading, or scrolling your phone can shift which brain regions light up and potentially affect the results. The actual scan takes about 30 minutes. You lie still on a table that slides into a large, ring-shaped scanner. It’s painless, though staying motionless can be uncomfortable.
How Results Are Interpreted
In a healthy brain, FDG uptake is roughly symmetrical. Certain regions naturally run hotter, including the visual cortex at the back of the brain, deep structures involved in movement control, and areas tied to attention and eye movement. The inner portions of the temporal lobe, by contrast, normally show somewhat lower activity. Your doctor or radiologist compares your scan against these expected patterns.
Asymmetry or unexpected cold spots can signal neurodegeneration, seizure foci, or the aftermath of a stroke. Unusually bright areas may indicate a tumor or active inflammation. The interpretation always happens in context, alongside your symptoms, medical history, and results from other tests.
How PET Differs From MRI and CT
CT scans use X-rays to produce quick, detailed images of bone and blood. They’re excellent for spotting fractures, bleeding, or large structural abnormalities, but they’re relatively poor at distinguishing between different types of brain tissue. MRI uses magnetic fields to create highly detailed images of soft tissue, making it the gold standard for visualizing brain anatomy, including grey and white matter differences and small structural lesions.
PET fills a fundamentally different role. Rather than showing what the brain looks like, it shows what the brain is doing. A tumor that appears stable on MRI might reveal aggressive metabolic activity on PET, changing the treatment approach. A brain that looks structurally normal on MRI might show the characteristic metabolic decline of early Alzheimer’s on PET. In many cases, PET and MRI are used together, with the structural detail of one overlaid on the functional data of the other.
Radiation Exposure
A brain PET scan delivers roughly 5 to 6 millisieverts (mSv) of radiation. For comparison, the average person absorbs about 3 mSv per year from natural background sources like cosmic rays and radon in soil. So a single brain PET is equivalent to about one and a half to two years of everyday background exposure. This is a modest dose in the context of medical imaging, though it’s one reason PET isn’t used for routine screening and is reserved for specific clinical questions where the diagnostic value clearly justifies it.